Nobody's funding your molecule anymore.

Jul 16, 2026

Nobody's funding your molecule anymore.

42 of 68 rounds this year went to drugs already in humans.

Read more
arrow-right
New molecule. No safety map.

Jul 9, 2026

New molecule. No safety map.

Here's how to create one and secure your road to the clinic.

Read more
arrow-right
$93M bought the asset. Did it buy the IND?

Jul 2, 2026

$93M bought the asset. Did it buy the IND?

There's always a data package, but that's not the same as IND-ready.

Read more
arrow-right
This week in nonclinical: the fence around your Phase 1, a GLP myth, and a free dosing card

Jun 25, 2026

This week in nonclinical: the fence around your Phase 1, a GLP myth, and a free dosing card

You think the clinic sets your trial's limits. Find out why it doesn't inside.

Read more
arrow-right
This week in nonclinical: a case study, a map and a poll

Jun 18, 2026

This week in nonclinical: a case study, a map and a poll

Learn the full nonclinical arc from start to IND

Read more
arrow-right
This week in nonclinical: investor translation, storytelling, and a quiz

Jun 11, 2026

This week in nonclinical: investor translation, storytelling, and a quiz

You see your data one way — how do others see it?

Read more
arrow-right